Finance

Beta
Lists
NSRX:NYSEAMERICAN
Nasus Pharma Ltd
$2.93
-9.57%
(-0.31) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NSRX...
Open
$3.14
High
$3.30
Low
$2.93
Mkt. cap
34.31M
Avg. vol.
80.58K
Volume
30.66K
52-wk high
$9.99
52-wk low
$1.98
EPS
-$1.45
Shares outstanding
11.71M
No. of employees
7
Open
$3.14
High
$3.30
Low
$2.93
Mkt. cap
34.31M
Avg. vol.
80.58K
Volume
30.66K
52-wk high
$9.99
52-wk low
$1.98
EPS
-$1.45
Shares outstanding
11.71M
No. of employees
7
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to NSRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for NSRX in the last 3 months.
Highest
Current $2.93
$18.00 (+514.33%)
Average
$18.00 (+514.33%)
Lowest
$18.00 (+514.33%)
News stories
From sources across the web
About Nasus Pharma Ltd
CEO-
Employees7
Founded2019
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
144.50K
144.50K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264.00K
264.00K
-
-
Operating expense
408.50K
408.50K
-
-
Total operating expenses
408.50K
408.50K
-
-
Operating income
-408.50K
-408.50K
-
-
Other non operating income
-25.50K
-25.50K
-
-
EBT including unusual items
-597.00K
-597.00K
-
-
EBT excluding unusual items
-434.00K
-434.00K
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-626.00K
-626.00K
-
-
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more